Is future LipoBalance Capsule approved by KKM / NPRA in Malaysia?

Yes, future LipoBalance Capsule is officially registered with the National Pharmaceutical Regulatory Agency (NPRA), Ministry of Health Malaysia under registration number MAL26086268T with status "PRODUCT APPROVED".

What are the generic alternatives for future LipoBalance Capsule in Malaysia?

There are 1 approved pharmaceutical formulations registered in Malaysia containing the same active ingredient (Lentinula Edodes), which can be compared for cost and availability.

MAL26086268TTraditional Herbal (MAL-T)

future LipoBalance Capsule

Q: What are the active ingredients of future LipoBalance Capsule?

The active ingredients of future LipoBalance Capsule as declared to NPRA are: Lentinula edodes 100 mg 650 mg, Cynara scolymus 100 mg 650 mg, Monascus purpureus 250 mg 650 mg.

Generic Molecule: Lentinula Edodes

ACTIVE & APPROVEDValid till: 6 Aug 2031

NPRA Official Regulatory Summary

future LipoBalance Capsule is a KKM-approved Traditional & Herbal registered under MAL number MAL26086268T by HERBAL SCIENCE SDN. BHD.. Its active ingredient is Lentinula edodes 100 mg 650 mg, Cynara scolymus 100 mg 650 mg, Monascus purpureus 250 mg 650 mg, manufactured by HERBAL SCIENCE SDN. BHD..

Holder (PRH)

HERBAL SCIENCE SDN. BHD.

Manufacturer

HERBAL SCIENCE SDN. BHD.

First Registered

6 Aug 2026

Validity

6 Aug 2031

Check Verified Pharmacy Stock & Best Price

Compare retail prices across licensed Malaysian pharmacies (Watsons, Guardian, Big Pharmacy, Shopee Mall).

Watsons MY Guardian MY

Active Ingredients & Strength Formulation

3 Components

Active Substance / Molecule	Declared Strength / Dosage	Generic Directory
Lentinula edodes	100 mg 650 mg	Find Brands
Cynara scolymus	100 mg 650 mg	Find Brands
Monascus purpureus	250 mg 650 mg	Find Brands

Dosage values indicate declared active concentration per unit dose as registered with NPRA Malaysia.

Sole Registered Brand Formulation

This product is currently the primary or innovator formulation registered in Malaysia under Lentinula Edodes.

Malaysian KKM Security Hologram Verification

FarmaChecker & Meditag™

By Malaysian Ministry of Health (KKM) regulation, all genuine registered pharmaceuticals, health supplements (MAL-N), and traditional products (MAL-T) distributed in Malaysia must feature an official tamper-evident security hologram sticker on the physical packaging.

1. Visual Tilt Check

Tilt the box under light to view the micro-engraved KKM coat of arms and multi-layer iridescent security patterns.

2. Match MAL Number

Ensure the printed MAL code matches MAL26086268T exactly on label and box.

3. FarmaChecker Scan

Scan using the official FarmaChecker app on iOS / Android to authenticate serial token with NPRA servers.

If the packaging lacks a security hologram or fails the FarmaChecker scan, do not consume and report to Cawangan Penguatkuasaan Farmasi (CPF KKM).

Frequently Asked Questions & Verification Details

Is future LipoBalance Capsule approved by KKM / NPRA?

Yes. future LipoBalance Capsule is actively registered with the National Pharmaceutical Regulatory Agency under official registration number MAL26086268T with current status PRODUCT APPROVED. Registration was filed by HERBAL SCIENCE SDN. BHD..

What are the active ingredients of future LipoBalance Capsule?

The declared active therapeutic components are: Lentinula edodes 100 mg 650 mg, Cynara scolymus 100 mg 650 mg, Monascus purpureus 250 mg 650 mg. Always follow dosage recommendations prescribed by a certified doctor or licensed pharmacist.

What are the registered generic alternatives in Malaysia?

In Malaysia, there are 1 registered brand formulations containing identical active ingredients (Lentinula Edodes). You can review them in the alternative brands section above or consult your community pharmacist for generic bioequivalent substitution.

Semakan status pendaftaran KKM / NPRA: future LipoBalance Capsule (MAL26086268T) | Pengganti ubat di Malaysia | Bahan aktif ubat & maklumat farmasi.